ACM
RLAY icon

Aquatic Capital Management’s Relay Therapeutics RLAY Stock Holding History

Aquatic Capital Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.25M Buy
120,197
+72,077
+150% +$1.05M 0.08% 336
2026
Q1 		$479K Buy
+48,120
New +$430K 0.01% 771
2023
Q2 		– Sell
-5,100
Closed -$84K – 1688
2023
Q1 		$84K Sell
5,100
-23,000
-82% -$412K 0.01% 786
2022
Q4 		$412K Buy
+28,100
New +$538K 0.03% 552

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Aquatic Capital Management's RLAY Position: Q2 2026 in Review

Aquatic Capital Management increased its Relay Therapeutics (RLAY) stake by 150% in Q2 2026, buying an estimated $1.05M and bringing the position to 120,197 shares worth $2.25M. The position accounts for 0.08% of the portfolio, ranked #336.

Aquatic Capital Management first reported a position in RLAY in Q4 2022 and has held it in 4 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Aquatic Capital Management held 120,197 shares of Relay Therapeutics worth $2.25M as of Q2 2026.
  • Aquatic Capital Management bought 72,077 Relay Therapeutics shares in Q2 2026, an estimated $1.05M.
  • Relay Therapeutics made up 0.08% of Aquatic Capital Management's portfolio in Q2 2026, its #336 holding.
  • Aquatic Capital Management first reported a position in Relay Therapeutics in Q4 2022 and has held it in 4 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.